Follicular development induced by recombinant luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in anovulatory women with LH and FSH deficiency: Evidence of a threshold effect

Current Medical Research and Opinion

Volumn 24, Issue 10, 2008, Pages 2785-2793

  O'Dea, Louis ^a   O'Brien, Fanny ^b   Currie, Karen ^c   Hemsey, George ^d  

^a Radius Health Inc   (United States)

^b GENZYME CORPORATION   (United States)

^c Citeline Inc   (United States)

^d EMD SERONO INC   (United States)

Author keywords

Anovulation; Follicular development; Hypogonadotrophic hypogonadism; r hFSH; r hLH; Recombinant luteinizing hormone; Threshold effect

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GONADOTROPIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE;

ABDOMINAL PAIN; ADULT; AMENORRHEA; ANEMIA; ANOVULATION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG FATALITY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DYSMENORRHEA; ERYTHEMA; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLICLE STIMULATING HORMONE DEFICIENCY; GONADOTROPIN BLOOD LEVEL; HORMONE DEFICIENCY; HUMAN; LIVER FUNCTION TEST; LUTEINIZATION; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE DEFICIENCY; MASTALGIA; MULTICENTER STUDY; NAUSEA; OVARY CYST; OVARY FOLLICLE DEVELOPMENT; OVARY HYPERSTIMULATION; OVULATION; PAIN; PARALLEL DESIGN; PELVIS PAIN SYNDROME; PREGNANCY; PROSPECTIVE STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN BRUISING; SWELLING;

ADOLESCENT; ADULT; AMENORRHEA; ANOVULATION; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; HORMONE REPLACEMENT THERAPY; HUMANS; LUTEINIZING HORMONE; OVARIAN FOLLICLE; PREGNANCY; RECOMBINANT PROTEINS;

EID: 55549139104     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/03007990802374815     Document Type: Article

References (30)

1. Jones JR Kemmann E. Olfacto-genital dysplasia in the female. Obstet Gynecol 1976;5:443-6
2. White BJ, Rogol AD, Brown KS. The syndrome of anosmia with hypogonadotropic hypogonadism: a genetic study of 18 new families and a review. Am J Med Genet 1983;15:417-35
3. Waldstreicher J, Seminara SB, Jameson JL, et al. The genetic and clinical heterogeneity of gonadotropin-releasing hormone deficiency in the human. J Clin Endocrinol Metab 1996;81:4388-95
4. Albanese C, Colin IM, Crowley WF, et al. The gonadotropin genes: evolution of distinct mechanisms for hormonal control. Recent Prog Horm Res 1996;51:23-58
5. Bick D, Franco B, Sherins RJ, et al. Brief report: intragenic deletion of the KALIG-1 gene in Kallmann's syndrome. N Engl J Med 1992-326:1752-5
6. Hardelin J-P, Soussi-Yanicostas N, Ardouin O, et al. Kallmann syndrome. Adv Otorbinolaryngol 2000;56:268-74
7. Georgopoulos NA, Pralong FP, Seidman CE, et al. Genetic heterogeneity evidenced by low incidence of KAL-1 gene mutations in sporadic cases of gonadotropin-releasing hormone deficiency. J Clin Endocrinol Metab 1997;82:213-7
8. Franco B, Guioli S, Pragliola A, et al. A gene deleted in Kattmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature 1991;353:529-36
9. Legouis R, Hardelin J-P, Levilliers J, et al. The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell 1991;67:423-35
10. de Roux N, Young J, Misrahi M, et al. Loss of function mutations of the GnRH receptor: a new cause of hypogonadotropic hypogonadism. J Pediatr Endocrinol Metab 1999;12(Suppl 1): 267-75
11. Habiby RL, Boepple P, Nachtigall L, et al. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalamic and pituitary defects in gonadotropin production. J Clin Invest 1996;98:1055-62
12. Short RV. Steroids in the follicular fluid and the corpus luteum of the mare. A 'two-cell type' theory of ovarian steroid synthesis. J Endocrinol 1962;24:59-63
13. Shoham Z, Balen AH, Patel A, et al. Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients. Fertil Steril 1991;56:1048-53
14. Couzinet B, Lestrat N, Brailly S, et al. Stimulation of ovarian follicular maturation with pure follicle stimulating hormone in women with gonadotropin deficiency. J Clin Endocrinol Metab 1988;66:552-6
15. Schoot DC, Coelingh Bennink H, Mannaerts B, et al. Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotropin deficiency. J Clin Endocrinol Metab 1992;74:1471-3
16. Hull M, Corrigan E, Piazzi A, et al. Recombinant human luteinising hormone: an effective new gonadotropin preparation. Lancet 1994;344:334-5
17. Balasch J, Miro F, Burzacoc I, et al. The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in vitro fertilization in a woman with long-standing hypogonadotropic hypogonadism using recombinant human follicle stimulating hormone. Hum Reprod 1995;10:1678-83
18. The European Recombinant Human LH Study Group. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. J Clin Endocrinol Metab 1998;83:1507-14
19. Levy DP, Navarro JM, Schattman GL, et al. The role of LH in ovarian stimulation. Hum Reprod 2000;15:2258-65
20. Chang P, Kenley S, Burns T, et al. Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel®) to urinary hCG (Profasi®) for induction of final follicular maturation in in vitro fertilization-embryo transfer. Fertil Steril 2001;76:67-74
21. le Cotonnec JY, Porchet HC, Beltrami V, et al. Clinical pharmacology of recombinant human luteinizing hormone: Part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with human luteinizing hormone. Fertil Steril 1998;69:189-94
22. le Cotonnec JY, Porchet HC, Beltrami V, et al. Clinical pharmacology of recombinant human luteinizing hormone: Part II. Bioavailability of recombinant human luteinizing hormone assessed with an immunoassay and in vitro bioassay. Fertil Steril 1998;69:195-200
23. le Cotonnec JY, Loumaye E, Porchet HC, et al. Pharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormone, Fertil Steril 1998;69:201-9
24. Kenigsberg D, Littman BA, Williams RF, et al. Medical hypophysectomy: II. Variability of ovarian response to gonadotropin therapy. Fertil Steril 1984;42:116-26
25. Karnitis VJ, Townson DH, Friedman CI, et al. Recombinant human follicle-stimulating hormone stimulates multiple follicular growth, but minimal estrogen production in gonadotropin-releasing hormone antagonist-treated monkeys: examining the role of luteinizing hormone in follicular development and steroidogenesis. J Clin Endocrinol Metab 1994;79:91-7
26. Zelinski-Wooten MB, Hutchison JS, Hess DL, et al. Follicle stimulating hormone alone supports follicle growth and oocyte development in gonadotrophin-releasing hormone antagonist-treated monkeys. Hum Reprod 1995;10:1658-66
27. Weston AM, Zelinski-Wooten MB, Hutchison JS, et al. Developmental potential of embryos produced by in vitro fertilization from gonadotropin-releasing hormone antagonist treated macaques stimulated with recombinant human follicle stimulating hormone alone or in combination with luteinizing hormone. Hum Reprod 1996;11:608-13
28. Mochtar MH, Van der Veen F, Ziech M, et al. Recombinant luteinizing hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database of Systematic Reviews 2007;Issue 2:CDO05070
29. Erickson GF, Shimasaki S. The physiology of folliculogenesis: the role of novel growth factors. Fertil Steril 2001;76:943-9
30. Palter SF, Tavares AB, Hourvitz A, et al. Are estrogens of import to primate/human ovarian folliculogenesis? Endocr Rev. 2001; 22:389-424